Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Thrombosis and Haemostasis|April 1, 1997
A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study GroupG C White, S Courter, G L Bray, et al.Critical Care Medicine|May 1, 1994
Erythropoietin response to critical illnessB Krafte-Jacobs, M L Levetown, G L Bray, et al.British Journal of Haematology|November 1, 1986
Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and BD J Nugent, G L Bray, R B Counts, et al.The Journal of Clinical Investigation|December 1, 1985
An intragenic deletion of the factor IX gene in a family with hemophilia BS H Chen, S Yoshitake, P F Chance, et al.American Journal of Hematology|April 1, 1993
Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort StudyG L Bray, B L Kroner, S Arkin, et al.Blood|May 1, 1994
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study GroupG L Bray, E D Gomperts, S Courter, et al.The Journal of Trauma|March 24, 1999
Multicenter trial to evaluate the safety and potential efficacy of pooled human fibrin sealant for the treatment of burn woundsD G Greenhalgh, R L Gamelli, M Lee, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia AM D Tarantino, P W Collins, C R M Hay, et al.Pageof 2